Development of antisense therapeutics. Implications for cancer gene therapy.
Milligan
J F
JF
Gilead Sciences, Foster City, California 94404.
Jones
R J
RJ
Froehler
B C
BC
Matteucci
M D
MD
D000818:Animals; D017209:Apoptosis; D001483:Base Sequence; D002455:Cell Division; D002463:Cell Membrane Permeability; D016373:DNA, Antisense / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D008969:Molecular Sequence Data; D009857:Oncogenes; D051381:Rats; D013329:Structure-Activity Relationship
D016373:DNA, Antisense